Shukra Pharmaceuticals begins trading on NSE, now dual-listed
SHUKRAPHAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shukra Pharmaceuticals got listed on the NSE on August 14, 2026 and its equity shares are now available for trading on both BSE and NSE. Media coverage by ANI highlighted the company's strategic focus on medical technology, artificial intelligence, and healthcare innovation. The company clarified that the coverage does not represent any new material agreement, contract, or transaction.
Dual listing on NSE may improve liquidity and investor visibility, though no new material business or deal was announced.